» Articles » PMID: 23184959

Characterization of a Novel α-conotoxin from Conus Textile That Selectively Targets α6/α3β2β3 Nicotinic Acetylcholine Receptors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Nov 28
PMID 23184959
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

α6β2 Nicotinic acetylcholine receptors (nAChRs) expressed by dopaminergic neurons in the CNS are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including nicotine addiction and Parkinson disease. However, recent studies indicate that the α6 subunit can also associate with the β4 subunit to form α6β4 nAChRs that are difficult to pharmacologically distinguish from α6β2, α3β4, and α3β2 subtypes. The current study characterized a novel 16-amino acid α-conotoxin (α-CTx) TxIB from Conus textile whose sequence is GCCSDPPCRNKHPDLC-amide as deduced from gene cloning. The peptide and an analog with an additional C-terminal glycine were chemically synthesized and tested on rat nAChRs heterologously expressed in Xenopus laevis oocytes. α-CTx TxIB blocked α6/α3β2β3 nAChR with an IC(50) of 28 nm. In contrast, the peptide showed little or no block of other tested subtypes at concentrations up to 10 μm. The three-dimensional solution structure of α-CTx TxIB was determined using NMR spectroscopy. α-CTx TxIB represents a uniquely selective ligand for probing the structure and function of α6β2 nAChRs.

Citing Articles

A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.

Wang W, Wang M, Wang H, Xu W, Wang C, Pei J Front Pharmacol. 2025; 15:1466504.

PMID: 39906393 PMC: 11790622. DOI: 10.3389/fphar.2024.1466504.


Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson's Disease?.

Silva J, Alves C, Soledade F, Martins A, Pinteus S, Gaspar H Mar Drugs. 2023; 21(8).

PMID: 37623732 PMC: 10455662. DOI: 10.3390/md21080451.


Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors.

Xie T, Qin Y, Zhao J, Dong J, Qi P, Zhang P Int J Mol Sci. 2023; 24(10).

PMID: 37239959 PMC: 10218596. DOI: 10.3390/ijms24108618.


Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages.

Tan Y, Chu Z, Shan H, Zhangsun D, Zhu X, Luo S Mar Drugs. 2022; 20(3).

PMID: 35323499 PMC: 8955479. DOI: 10.3390/md20030200.


Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.

Kasheverov I, Kudryavtsev D, Shelukhina I, Nikolaev G, Utkin Y, Tsetlin V Biomolecules. 2022; 12(2).

PMID: 35204690 PMC: 8961598. DOI: 10.3390/biom12020189.


References
1.
Lof E, Olausson P, deBejczy A, Stomberg R, McIntosh J, Taylor J . Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. Psychopharmacology (Berl). 2007; 195(3):333-43. DOI: 10.1007/s00213-007-0899-4. View

2.
Klimis H, Adams D, Callaghan B, Nevin S, Alewood P, Vaughan C . A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain. Pain. 2010; 152(2):259-266. DOI: 10.1016/j.pain.2010.09.007. View

3.
Santos A, McIntosh J, Hillyard D, Cruz L, Olivera B . The A-superfamily of conotoxins: structural and functional divergence. J Biol Chem. 2004; 279(17):17596-606. DOI: 10.1074/jbc.M309654200. View

4.
Ellison M, Haberlandt C, Gomez-Casati M, Watkins M, Elgoyhen A, McIntosh J . Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR. Biochemistry. 2006; 45(5):1511-7. DOI: 10.1021/bi0520129. View

5.
Gehrmann J, Alewood P, Craik D . Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability. J Mol Biol. 1998; 278(2):401-15. DOI: 10.1006/jmbi.1998.1701. View